RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-κB
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The members of tumor necrosis factor receptor (TNFR) superfamily have been designated as the “guardians of the immune system” due to their roles in immune cell proliferation, differentiation, activation, and death (apoptosis). This study reports the cloning of a new member of the TNFR superfamily, RELT (ReceptorExpressed in Lymphoid Tissues). RELT is a type I transmembrane glycoprotein with a cysteine-rich extracellular domain, possessing significant homology to other members of the TNFR superfamily, especially TNFRSF19, DR3, OX40, and LTβ receptor. The messenger RNA of RELT is especially abundant in hematologic tissues such as spleen, lymph node, and peripheral blood leukocytes as well as in leukemias and lymphomas. RELT is able to activate the NF-κB pathway and selectively binds tumor necrosis factor receptor-associated factor 1. Although the soluble form of RELT fusion protein does not inhibit the one-way mixed lymphocyte reaction, immobilized RELT is capable of costimulating T-cell proliferation in the presence of CD3 signaling. These results define a new member of the TNFR superfamily that may be a potential regulator of immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Self-citationA homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Research works printed but not linked: 28
- Smith, 1994, The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death., Cell., 76, 959, 10.1016/0092-8674(94)90372-7 · DOI · Paper page
- Cosman, 1994, A family of ligands for the TNF receptor superfamily., Stem Cells., 12, 440, 10.1002/stem.5530120501 · DOI · Paper page
- Gruss, 1996, Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease., Ann Oncol., 7, 19, 10.1093/annonc/7.suppl_4.S19 · DOI
- Chinnaiyan, 1996, Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95., Science., 274, 990, 10.1126/science.274.5289.990 · DOI · Paper page
- Eby, 2000, TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death., J Biol Chem., 275, 15336, 10.1074/jbc.275.20.15336 · DOI · Paper page
- Kojima, 2000, TROY, a newly identified member of the tumor necrosis factor receptor superfamily exhibits a homology with Edar and is expressed in embryonic skin and hair follicles., J Biol Chem., 275, 20742, 10.1074/jbc.M002691200 · DOI · Paper page
- Schwenzer, 1999, The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase., J Biol Chem., 274, 19368, 10.1074/jbc.274.27.19368 · DOI · Paper page
- Arch, 1998, Tumor necrosis factor receptor-associated factors (TRAFs)—a family of adapter proteins that regulates life and death., Genes Dev., 12, 2821, 10.1101/gad.12.18.2821 · DOI · Paper page
- von Bulow, 1997, NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily., Science., 278, 138, 10.1126/science.278.5335.138 · DOI · Paper page
- Chapoval, 2000, In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells., Blood., 95, 2346, 10.1182/blood.V95.7.2346 · DOI
- Tamada, 2000, Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway., Nature Med., 6, 283, 10.1038/73136 · DOI · Paper page
- Hu, 1999, Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily., Genomics., 62, 103, 10.1006/geno.1999.5979 · DOI
- Yu, 1999, A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis., J Biol Chem., 274, 13733, 10.1074/jbc.274.20.13733 · DOI · Paper page
- Weinberg, 1998, OX-40: life beyond the effector T cell stage., Semin Immunol., 10, 471, 10.1006/smim.1998.0146 · DOI
- Fu, 1999, Development and maturation of secondary lymphoid tissues., Annu Rev Immunol., 17, 399, 10.1146/annurev.immunol.17.1.399 · DOI · Paper page
- Katsura, 1996, Identification of the proteolytic enzyme which cleaves human p75 TNF receptor in vitro., Biochem Biophys Res Commun., 222, 298, 10.1006/bbrc.1996.0738 · DOI
- Michel, 1998, A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis., Eur J Immunol., 28, 290, 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S · doi:10.1002/(sici)1521-4141(199801)28:01<290::aid-immu290>3.0.co;2-s
- Hughes, 1995, A naturally occurring soluble isoform of murine Fas generated by alternative splicing., J Exp Med., 182, 1395, 10.1084/jem.182.5.1395 · DOI · Paper page
- Ghosh, 1998, NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses., Annu Rev Immunol., 16, 225, 10.1146/annurev.immunol.16.1.225 · DOI · Paper page
- Rothe, 1994, A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor., Cell., 78, 681, 10.1016/0092-8674(94)90532-0 · DOI · Paper page
- Irmler, 2000, Caspase-induced inactivation of the antiapoptotic TRAF1 during Fas ligand-mediated apoptosis., FEBS Lett., 468, 129, 10.1016/S0014-5793(00)01206-0 · DOI
- Speiser, 1997, A regulatory role for TRAF1 in antigen-induced apoptosis of T cells., J Exp Med., 185, 1777, 10.1084/jem.185.10.1777 · DOI
- Wang, 1998, NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation., Science., 281, 1680, 10.1126/science.281.5383.1680 · DOI · Paper page
- Messineo, 1998, Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation., Blood., 91, 2443, 10.1182/blood.V91.7.2443 · doi:10.1182/blood.v91.7.2443
- Durkop, 1999, Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells., Blood., 93, 617, 10.1182/blood.V93.2.617 · DOI
- Pollok, 1994, 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells., Eur J Immunol., 24, 367, 10.1002/eji.1830240215 · DOI · Paper page
- Langstein, 1998, CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling., J Immunol., 160, 2488, 10.4049/jimmunol.160.5.2488 · doi:10.4049/jimmunol.160.5.2488
- Desbarats, 1998, Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells., Nature Med., 4, 1377, 10.1038/3965 · DOI
Cited by
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Self-citationGlucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
The signaling adaptors and pathways activated by TNF superfamily
Dempsey, P. W., Doyle, S. E., He, J. Q., & Cheng, G. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00021-2 · Cited by 504
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
Metadata
- Authors
- Sica, G. L., Zhu, G., Tamada, K., Liu, D., Ni, J., & Chen, L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-05-01
- Volume
- 97
- Issue
- 9
- Pages
- 2702-2707
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2051305116
- Cited by
- 71
- References
- 2
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-κB. https://app.cochat.ai/papers/10.1182/blood.v97.9.2702
- The paper
- Sica, G. L., Zhu, G., Tamada, K., Liu, D., Ni, J., & Chen, L. (2001). RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-κB. Blood. https://doi.org/10.1182/blood.v97.9.2702
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.